More than 200 patient, consumer, industry, research, and government stakeholders joined the Foundation’s Annual Public Meeting of our Board of Directors on May 16, 2022. The event featured candid discussions with senior FDA leadership on topics ranging from data interoperability, food safety, and FDA’s plans for a return to in-person events. See highlights from the meeting below.

On May 12, 2021, more than 100 stakeholders joined Reagan-Udall Foundation for the FDA Board of Directors for their Annual Public Meeting. The discussion centered on how public-private partnerships help advance the mission of FDA. Board members joined FDA leaders to highlight the impact of cross-cutting collaborations – especially in the last year as we faced unprecedented public health challenges. 

Collaboration and partnership, two key aspects of the Reagan-Udall Foundation for the FDA’s commitment to advancing regulatory science, were on full display when leaders from the FDA, the regulatory science community and the medical community gathered in Washington DC on Friday May 4, 2018 for the Foundation’s annual meeting.